NDC 68180-761 - Nadolol

This NDC is not currently matched to an FDA NDC product listing in FDA.report, but it is a valid NDC-form code. FDA.report is showing the available DailyMed label context for the product root.

Product NDC: 68180-761
Package NDCs from labels: 68180-761-06, 68180-761-01, 68180-761-03
Manufacturer: Lupin Pharmaceuticals, Inc. | LUPIN LIMITED
Effective date: 2018-10-26
Current FDA listing: Not matched in FDA.report NDC product tables

DailyMed Labels#

Label, Manufacturer, Effective date table
Label	Manufacturer	Effective date	Type
Nadolol - Lupin Pharmaceuticals, Inc. \| LUPIN LIMITED	Lupin Pharmaceuticals, Inc. \| LUPIN LIMITED	2018-10-26	HUMAN PRESCRIPTION DRUG LABEL

DailyMed Package Descriptions#

Package NDC, Product, Description table
Package NDC	Product	Description	Form	Quantity	SPL version
68180-761-01	Nadolol	100 in 1 BOTTLE	TABLET	100	2
68180-761-03	Nadolol	1000 in 1 BOTTLE	TABLET	1000	2
68180-761-06	Nadolol	30 in 1 BOTTLE	TABLET	30	2

DailyMed Dashboard NDC Coverage#

NDC, Dashboard title, SPL version table
NDC	Dashboard title	SPL version	Validation	Dashboard ZIP
68180-761	NADOLOL TABLET [LUPIN PHARMACEUTICALS, INC.]	2	3 package rows	20181031_c9d8933e-14fd-4859-b7ba-933f9dfc4788.zip

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 36 of 36 · 701 matching rows.

Brand, Generic, Manufacturer table
Brand	Generic	Manufacturer	SPL set ID	Effective date	Available safety fields	Join
CPDA-1	ANTICOAGULANT CITRATE PHOSPHATE DEXTROSE ADENINE	Fenwal, Inc.	051f7347-5a76-4664-8fe2-e61b3dfcb0e4	2014-08-27		Exact identifier unii: XF417D3PSL

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.